EQRx Revenue and Competitors
Estimated Revenue & Valuation
- EQRx's estimated annual revenue is currently $31.3M per year.
- EQRx's estimated revenue per employee is $150,500
- EQRx's total funding is $1.9B.
- EQRx's current valuation is $1.2B.
Employee Data
- EQRx has 208 Employees.
- EQRx grew their employee count by -34% last year.
EQRx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Sr. VP, Clinical Operations | Reveal Email/Phone |
3 | Chief Regulatory Affairs | Reveal Email/Phone |
4 | Chief Physician Executive | Reveal Email/Phone |
5 | CEO | Reveal Email/Phone |
6 | Chief Rx Creation | Reveal Email/Phone |
7 | Chief Technical Operations and Quality | Reveal Email/Phone |
8 | Chief Executive Physician | Reveal Email/Phone |
9 | VP, Alliance Management | Reveal Email/Phone |
10 | SVP, Biologics | Reveal Email/Phone |
EQRx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.3M | 208 | -34% | $1.9B | $1.2B |
What Is EQRx?
EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
keywords:N/A
$1.9B
Total Funding
208
Number of Employees
$31.3M
Revenue (est)
-34%
Employee Growth %
$1.2B
Valuation
N/A
Accelerator
EQRx News
Jefferies Financial Group initiated coverage on EQRx in a research note on Friday, March 18th. They set a buy rating and a $5.60 price target...
Zero analysts have provided estimates for EQRx's earnings. The business is expected to issue its next quarterly earnings results on Monday,...
EQRx's aim is for the purchasing network to support its first two drugs and others that come along. The company has a portfolio of eight other...
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today launched a multi-part corporate video series entitled “Remaking Medicine: On The Record.” The series is moderated by Jami Rubin, EQRx’s chief fin ...
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. Just a few days after EQRx announced its intent to merge with Eli Casdin’s third blank check company, another SPAC deal is wrapped up and ready for Nasdaq. RNA ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.3M | 209 | -3% | N/A |
#2 | $48.3M | 209 | -5% | N/A |
#3 | $32.6M | 212 | 20% | N/A |
#4 | $24M | 214 | -1% | N/A |
#5 | $6.2M | 217 | -1% | $395.5M |